A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia
A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia
Active, not recruiting · NCT07052006 · Registry updated 2026-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia | Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Active, not recruiting | Phase 2 | 2026-09-17 | NCT07052006 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Halia Therapeutics, Inc. | 3 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| All India Institute of Medical Sciences | Dehradun | India | 1 |
| Apollo Cancer Centre | Hyderabad | India | 1 |
| Dr. Bafna's Star Superspeciality Clinic and Hospital | Kolhāpur | India | 1 |
| HCG Cancer Center Vizag | Visakhapatnam | India | 1 |
| Hemato Oncology Clinica Ahmedabad Pvt. Ltd. Vedanta Institute of Medical Sciences | Ahmedabad | India | 1 |
| Malabar Cancer Center | Kannur | India | 1 |
| Meenakshi Mission Hospital and Research Centre | Madurai | India | 3 |
| Nil Ratan Sircar Medical College and Hospital | Kolkata | India | 9 |
| Shalby Hospital | Ahmedabad | India | 2 |
| Tata Medical Center | Kolkata | India | 8 |